Intelligent Autoimmune Care Management

Automated disease activity calculators for rheumatoid arthritis with lab auto-population and longitudinal trending. One of the very few Indian clinic systems with built-in rheumatology scoring tools.

• One-tap DAS28-ESR and DAS28-CRP calculators with interactive joint homunculus for tender and swollen joint counts. ESR and CRP values auto-populate from lab results, eliminating manual lookup.
• CDAI (Clinical Disease Activity Index) and SDAI (Simplified Disease Activity Index) scoring for patients where ESR/CRP-based scoring is unreliable, such as those on tocilizumab.
• Colour-coded disease activity classification: remission, low, moderate, and high disease activity displayed as trend charts across all visits.
• Treat-to-target alerts: when DAS28 or CDAI remains above remission threshold for two consecutive visits, the system flags the patient for therapy escalation during the consultation.
• Score history integrates directly with the prescription workflow. When writing a biologic prescription or switching therapy, the DAS28/CDAI trend is visible on the same screen, enabling evidence-based dosing decisions.

Dedicated scoring and monitoring for ankylosing spondylitis and axial spondyloarthropathy with biologic eligibility assessment.

• BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) calculator with patient-reported outcome capture for fatigue, spinal pain, joint pain, enthesitis, and morning stiffness.
• BASFI (Bath Ankylosing Spondylitis Functional Index) for functional impairment documentation alongside disease activity.
• ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score) with CRP auto-populated from lab results, giving a more objective activity measure than BASDAI alone.
• Biologic eligibility flagging: when BASDAI crosses 4 and two or more NSAIDs have failed (documented in the system), the patient is flagged for biologic initiation per Indian Rheumatology Association guidelines.
• Longitudinal BASDAI/ASDAS trend charts allow visual correlation of disease activity with biologic therapy start and switch dates.

End-to-end biologic and targeted synthetic DMARD lifecycle management, from pre-screening through infusion scheduling to long-term safety monitoring.

• Pre-biologic screening checklist: TB screening (QuantiFERON/Mantoux), hepatitis B surface antigen, hepatitis C antibody, chest X-ray, CBC, and LFT. Each item is tracked as completed or pending.
• Biologic dosing schedule with infusion and subcutaneous injection date tracking. Supports rituximab, tocilizumab, adalimumab, etanercept, secukinumab, tofacitinib, baricitinib, and upadacitinib protocols.
• Auto-reminders for upcoming infusions and injections sent to patients via the patient app and SMS.
• Adverse event monitoring with structured capture of infections, infusion reactions, injection site reactions, and cytopenias. Linked to the biologic record for safety auditing.
• Biologic switching documentation with reason coding (primary non-response, secondary loss of efficacy, adverse event) and wash-out period tracking between agents.

Centralised longitudinal tracking of autoantibodies and immunological markers across all connective tissue diseases, with results auto-synced from the lab module.

• ANA, anti-dsDNA, anti-Smith, anti-Ro/SSA, anti-La/SSB, and anti-CCP trend charts with titre tracking over time.
• Rheumatoid factor (RF) and anti-CCP auto-populated into DAS28 workflow context so doctors see seropositivity status alongside disease activity scores.
• ANCA panel (c-ANCA, p-ANCA, MPO, PR3) monitoring for vasculitis patients with longitudinal trend views.
• Complement levels (C3, C4, CH50) trending for lupus nephritis activity assessment alongside anti-dsDNA and urine protein.
• ESR and CRP values auto-flow from the lab module into DAS28 and ASDAS calculators, eliminating double entry. When a new lab result arrives, the next disease activity score can be calculated immediately.

Smart prescription templates for conventional DMARDs, biologics, and supportive therapy with automated safety monitoring schedules.

• Methotrexate protocol templates with automatic folic acid co-prescription, and CBC + LFT monitoring reminders at 6-week intervals.
• DMARD combination bundles: MTX + HCQ + SSZ, MTX + leflunomide, and other standard Indian Rheumatology Association protocols available as F1-F12 shortcut prescriptions.
• Corticosteroid taper protocols with cumulative dose tracking. When cumulative prednisolone exceeds thresholds, osteoporosis risk alerts and calcium/vitamin D co-prescription reminders trigger automatically.
• Biologic prescriptions linked to DAS28/BASDAI scores: the system shows the current disease activity score alongside the prescription, so biologic initiation and dose changes are documented with clinical justification.
• Anti-duplicate check prevents accidental overlapping of similar drug classes (e.g., two biologics, two JAK inhibitors), a critical safety feature for complex rheumatology regimens.

Patients call in for appointment booking, hear real-time slot availability, and receive automated reminders for biologic infusion dates and follow-up visits.

• Automated appointment booking with real-time slot availability for OPD consultations and biologic infusion sessions.
• Auto-reminders for biologic infusion appointments, DMARD monitoring lab visits, and disease activity assessment follow-ups.
• GPS-based smart queue so rheumatology patients with mobility issues know the optimal time to arrive and minimize waiting.
• Zero double-booking engine prevents scheduling conflicts for infusion chair slots and doctor consultations.

Nurses capture joint symptoms, morning stiffness duration, functional status, and vitals before the consultation using the Octa module.

• Voice-assisted capture of morning stiffness duration, joint pain locations, fatigue scores, and functional limitations.
• Previous DAS28, BASDAI, and lab values auto-loaded into the consultation screen for immediate trend review.
• Critical flags for abnormal CBC (methotrexate patients), elevated liver enzymes, or rising CRP that require urgent attention.
• Patient-reported outcome measures (PROMs) for BASDAI and HAQ-DI captured digitally before the doctor consultation.

Patients access prescriptions, biologic schedules, lab results, and disease activity scores on their phone.

• Digital prescriptions with medication reminders for weekly methotrexate, daily DMARDs, and biologic injection dates.
• Biologic infusion schedule visible in the app with reminders and rescheduling capability.
• Follow-up reminders for disease activity assessments, DMARD monitoring labs, and annual screening tests.
• Secure messaging for patients to report flares, medication side effects, or queries between visits.